IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12040052 B1

PDFFull Text
Date of Patent:
Jul. 16, 2024

Filed:

Sep. 18, 2020

Bambam: parallel comparative analysis of high-throughput sequencing data

Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

John Zachary Sanborn, Santa Cruz, CA (US);

David Haussler, Santa Cruz, CA (US);

Assignee:

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, Oakland, CA (US);

Attorney:

Kilpatrick Townsend & Stockton LLP

Primary Examiner:

Mary K Zeman

Int. Cl.
CPC ...
G16B 30/10 (2019.01); C12Q 1/6886 (2018.01); G06F 3/04845 (2022.01); G06F 40/169 (2020.01); G06N 7/01 (2023.01); G06T 11/20 (2006.01); G16B 20/20 (2019.01); G16B 30/00 (2019.01); G16B 40/00 (2019.01); G16H 50/20 (2018.01); G16H 10/40 (2018.01); G16H 10/60 (2018.01); G16H 70/20 (2018.01);
U.S. Cl.
CPC ...
G16B 30/10 (2019.02); C12Q 1/6886 (2013.01); G06F 3/04845 (2013.01); G06F 40/169 (2020.01); G06N 7/01 (2023.01); G06T 11/206 (2013.01); G16B 20/20 (2019.02); G16B 30/00 (2019.02); G16B 40/00 (2019.02); G16H 50/20 (2018.01); C12Q 2600/106 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/156 (2013.01); G06F 2203/04806 (2013.01); G16H 10/40 (2018.01); G16H 10/60 (2018.01); G16H 70/20 (2018.01); Y02A 90/10 (2018.01); Y02A 90/30 (2018.01);
Abstract

The present invention relates to methods for evaluating and/or predicting the outcome of a clinical condition, such as cancer, metastasis, AIDS, autism, Alzheimer's, and/or Parkinson's disorder. The methods can also be used to monitor and track changes in a patient's DNA and/or RNA during and following a clinical treatment regime. The methods may also be used to evaluate protein and/or metabolite levels that correlate with such clinical conditions. The methods are also of use to ascertain the probability outcome for a patient's particular prognosis.

Find Patent Forward Citations

Loading…